This paper would be more relevant if most science came down to evaluating a single p-value. Perhaps there are some fields of science where that is true, but I have not encountered them. I mostly look at molecular biology and infectious disease. Clinical trials in medicine come down to a single p-value by design, but don't fall prey to what he's talking about.